Substance-related disorders treatment service in a general hospital in Ethiopia: Experience, challenges and opportunities by Teferra, Solomon
African Journal of Drug & Alcohol Studies, 17(1), 2018
Copyright © 2018, CRISA Publications
SUBSTANCE-RELATED DISORDERS TREATMENT SERVICE IN A GENERAL HOSPITAL 
IN ETHIOPIA: EXPERIENCE, CHALLENGES AND OPPORTUNITIES
Solomon Teferra
Department of Psychiatry, School of Medicine, College of Health Sciences, 
Addis Ababa University, Ethiopia
ABSTRACT
According to the latest global burden of diseases report, substance related disorders 
(SRDs) remain important risk factors for disability and premature mortality. The sub-
Saharan Africa region has a long history of substance use, but this was mainly limited 
to alcohol, tobacco, cannabis, and khat. Recently, use of hard drugs such as cocaine 
and heroin is on the rise. This paper highlights the current status of SRDs in Ethiopia. 
Alcohol, khat and tobacco are the three substances commonly misused in Ethiopia. 
Evidence based interventions for SRDs for low and middle-income countries (LMICs) 
and the challenges of setting up SRD service, and application of these interventions in 
Ethiopia, a country of more than 100 million people and the second largest in Africa 
after Nigeria with rising SRDs, is presented. It also highlights the successes, opportunities 
and innovative approaches undertaken. A descriptive summary of cases seen in the SRD 
treatment center, and outcomes of detoxification is also presented. Lessons learnt in 
this process have the potential to inform other similar services in LMICs. 
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INTRODUCTION 
Substance related disorders (SRDs) are 
global problems, affecting virtually hu-
man beings living anywhere in the world, 
though prevalence figures vary. According 
to global burden of diseases (GBD) report 
of 2016, alcohol and drugs accounted 
for 4.2% and 1.3 of all disability adjusted 
life years (DALYs) respectively. Alcohol 
remained the most commonly missed 
substance with age-standardized preva-
lence 1320·8 cases per 100 000 people 
followed by cannabis and opioids with 
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age-standardized prevalence 289·7 cases 
per 100 000 people and age-standard-
ized prevalence 353·0 cases per 100 000 
people respectively (GBD 2016 Alcohol 
and Drug Use Collaborators, 2018). Alco-
hol misuse alone was found to be the 7th 
leading risk factor for mortality and DALYs 
(GBD 2016 Alcohol Collaborators, 2018).
Sub-Sahara Africa region faces the dou-
ble burden of infectious diseases such as 
HIV, TB, malaria and non-communicable 
diseases (NCDs) including MNS disorders 
(Angkurawaranon et.al., 2016, Misga-
naw et.al., 2017) . These countries are 
undergoing socioeconomic and cultural 
transition, with emerging middle class 
who have disposable income for buy-
ing alcohol and recreational substances. 
Among the four risk factors identified by 
WHO to predispose individuals to NCDs 
excessive alcohol use remains the most 
prevalent factor and widely consumed in 
Africa (Obot, 2007); alcohol was reported 
to be the leading risk factor for NCDs in 
Southern Africa, and among the top ten 
risk factors in the rest of sub-Saharan 
Africa region (Obot, 2013). Big multina-
tional alcoholic beverage industries have 
found a new niche in this region, invest-
ing billions of dollars and engaging in ag-
gressive marketing of alcoholic drinks, 
dubbed neocolonialism by some authors 
(Willis, 2006). For instance, the largest 
investment in Ethiopia from Europe was 
in the brewery industry increasing the 
production of beer more than 10 fold in 
a span of less than 20 years (Teferra et. 
al., 2017).
Most commonly used substances in 
many African countries include alcohol, 
tobacco, cannabis and khat (Odejide, 
2006). Use of illicit drugs is more common 
among at risk populations such as street 
youth (Fekadu, Alem & Hanlon, 2006) 
Use of other substances such as opi-
oids is on the rise in Africa. A review of 
injecting drug use in six African countries, 
namely Egypt, Kenya, Mauritius, Nigeria, 
South Africa and Tanzania reported ris-
ing trend of injecting drug use despite 
widespread belief on the contrary; more-
over, the practice of IDU was unsafe and 
posed high risk for HIV infection (Dewing 
et. al., 2006). Factors contributing to the 
increasing misuse of drugs and alcohol in 
Africa include poverty, political instability, 
social unrest and refugee problems (ode-
jide, 2006). The impact of globalization 
on the spread of more potent addictive 
substances such as heroin, cocaine and 
ecstasy in Africa is also noteworthy (ode-
jide, 2006). Africa has also become a drug 
trafficking hub for high potent drugs such 
as cocaine, with Nigeria playing a major 
role (US DEA, 2001).
Background about Ethiopia
Ethiopia is one of the ancient civiliza-
tions in the world situated in what is com-
monly known as the horn of Africa in the 
Eastern African region. It is the second 
most populous country in Africa after Ni-
geria with a population of more than 100 
million, making it home to nearly 10 per-
cent of the African people (www.worldat-
las.com/articles/the-10-most-populated-
countries-in-Africa.html). Although known 
to the wider world with images of the 
devastating famine that occurred in the 
1980s, it has shown remarkable economic 
development in the past two decades re-
sulting in significant reduction in the level 
of poverty, and improvement in the pro-
vision of basic services (www.worldbank.
org/en/country/ethiopia/overview). 
Ethiopia is one of the five ancient civili-
zations in the world, and among the first 
to produce alcoholic beverages in the 
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world (Fekadu, Alem & Hanlon, 2007). It 
is also the origin of two stimulants: cof-
fee and khat (Berecha et.al., 2015; Geta-
setegn, 2016). Being a conservative coun-
try, with almost all the citizens subscrib-
ing to one or the other major religions in 
the world, many people think substance 
misuse is not a problem. In fact, there is 
evidence that substance misuse is on the 
rise (Bekele, Gebremedhin, …& Teferra, 
2017). Increasing urbanization, economic 
boom, high unemployment rate and cul-
tural transition have probably contribut-
ed to the rise of substance misuse. 
The health system in Ethiopia is orga-
nized around primary health care, pre-
vention being its primary focus. Currently 
the country has about 70 psychiatrists, a 
few hundred psychiatry nurses and only 
one addiction psychiatrist. The resources 
allocated for health, mostly donor fund-
ed, focus mainly on communicable dis-
eases such as malaria, TB and HIV; and 
maternal and child health (MoH, 2015). 
Non-communicable diseases are emerg-
ing health problems being responsible for 
24% of deaths in Addis Ababa (Misganaw 
et.al., 2014).
Prevalence of substance use in Ethiopia
In Ethiopia, national data exists on three 
substances that are commonly misused- 
alcohol, khat and tobacco. According 
to a recent national representative sur-
vey involving close to 10,000 adults, the 
prevalence of heavy episodic drinking was 
reported to be 12.4%; the proportion of 
current khat chewing was 15.8% and the 
prevalence of tobacco smoking was 4.2%. 
(Please see table-1 for further details)
Studies on other substances are lim-
ited to specific social groups and areas. 
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Table 1. Alcohol, Khat and Tobacco use among Ethiopians: Findings from the 2015 
STEPS Survey*
Results for age 15-69 year olds Females, n(%) Males, n(%) Both sexes, n(%)
Tobacco Use
Current smokers 0.4(0.3-0.6) 7.3(6.1-8.6) 4.2(3.5-4.9)
Daily tobacco smokers 0.2(0.1-0.4) 6.2(5.0-7.4) 3.5(2.8-4.1)
Among daily smokers 
Average age in years of debut for smoking 22.8(19.1-26.5) 20.9(19.8-22.0) 21.0(19.9-22.0)
Daily smokers using manufactured cigarettes 48.4(26.5-70.3) 91.5(87.4-95.5) 89.4(85.3-93.6)
Average number of cigarettes smoked daily 2.4(1.1-3.7) 7.3(6.2-8.3) 7.1(6.1-8.1)
Alcohol consumption
Life time alcohol use 2318 (42.7) 2012 (54.9) 4330 (49.3)
Past 12 month drinkers from ever drinkers 2045 (88.2) 1818 (90.4) 3863 (89.6)
Current drinkers (past 30 days) 1793 (89.4) 1709 (93.6) 3502 (92.0)
Heavy episodic drinking (? 6 or more drinks/
occasion in the past 30 days
2.7% 20.5% 12.4% 
Khat chewing
Current Khat chewers (past 30 days) 9.4 (7.2-11.5 21.1 (17.6-24.7) 15.8 (13.1-18.5)
Among the chewers during the past 12 months, 
percentage of respondents who chew Khat daily.
50.4(41.7-59.2) 61.4 (53.9-68.8) 58.4 (51.6-65.2)
* (Defar, Getachew, Teklie, Bekele, Gonfa…Teferra, 2017; Teklie, Gonfa, Getachew, Defar, Bekele…Teferra, 
2017; Getachew, Defar, Teklie, Gonfa, Bekele….Teferra, 2017)
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According to an old study, the propor-
tion of gasoline sniffing among juvenile 
delinquents was 17% (Workneh, 1983); 
a rapid assessment involving street chil-
dren, commercial sex workers and street 
vendors in the capital and several other 
towns in Ethiopia reported 11.2% canna-
bis use, 0.9% solvent use, 0.2% cocaine 
and heroin use each (Selassie, 1996). 
Currently, the use of cannabis is increas-
ing significantly, especially in urban areas. 
Current Status of Services for SRDs in 
low and middle income countries 
In general, there is a dearth of evi-
dence for alcohol and drug abuse services 
in LMICs. Most of the evidence for such 
services comes from high income coun-
tries, which depend on costly care models 
of treatment and rehabilitation. A recent 
review on packages of care for mental 
health services in LMICs, published in a 
series of articles on Plos Medicine focused 
on evidence based interventions for alco-
hol use disorders (AUDs). According to this 
recommendation, AUDs are neglected 
health problems in LMICs, most problem-
atic drinkers visit primary care and remain 
untreated, and the small existing services 
focus mainly on tertiary care for severe 
dependent patients. The recommenda-
tion called for a shift in policy towards 
cost effective interventions focusing on 
brief intervention for non dependent us-
ers who form the majority of problem-
atic users. It shies away from the effective 
evidence based psycho-social and phar-
macological interventions due to cost 
and emphasizes possible stepped care 
model (Benegal, Chand & Obot, 2009). 
However, a later publication covering the 
whole range of SRDs took the bold step 
of presenting comprehensive packages of 
evidence-based care for LMICs which was 
later incorporated in the landmark WHO-
mhGAP intervention guide (Please see 
table-2 for details). 
Challenges of SRD Service in Low and 
Middle Income Countries 
Although SRDs are recognized as im-
portant public health problems in LMICs 
that need attention, more than a third of 
LMIC countries have no policy on alcohol 
and drugs. The mental health budget of 
most countries is below 1% of their health 
budget, and often SRDs get none of this 
budget allocated due to high level of stig-
ma. Challenges include lack of policies, 
strategies and legislations, poor financ-
ing, poor capacity, and diverse treatment 
approaches, which may not be evidence-
based (Salwan and Katz, 2014).
The Situation SRD service in Ethiopia
In Ethiopia, SRD services are better 
described as non-existent; the country 
doesn’t have alcohol and drug policy, 
or strategy. There is a five-year National 
Drug Master Plan supported by the Unit-
ed Nations Office for Drug and Crime 
(UNODC), but implementation is only 
limited to training using Treatnet proto-
col (https://www.unodc.org), and some 
awareness raising activities, usually un-
dertaken by the drug control author-
ity, Ethiopian Food Medicine and Health 
Care Administration and Control Author-
ity (EFMHACA). This institution provided 
some support for setting up detoxification 
services, one a 10 bed facility in the only 
mental hospital, Amanuel Mental Special-
ized hospital, and a 5 bed detoxification 
facility in a general hospital, both located 
in the capital city. There is no dedicated 
budget for the services, or provision of 
inputs on a regular basis. SRD related 
activities are not included in the Health 
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Management Information System (HMIS) 
reporting. The author, who is an addic-
tion psychiatrist trained at the University 
of Toronto in Canada, has been providing 
SRD services in another general hospital 
for the past five years and established a 
4 bed detoxification service in the same 
hospital 2 years ago. 
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Table 2. Evidence-based Recommendations for Management of SRDs in LMICs** 
Alcohol use disorders Detailed description of the interventions 
Screening and brief interventions Routine screening in clinics using validated instruments such as AUDIT-3, 
AUDIT-C, ASSIST, brief intervention for hazardous and harmful alcohol use
Management of alcohol 
withdrawal
Supported withdrawal in patients with alcohol dependence, use 
benzodiazepines first-line medication for the management of alcohol 
withdrawal. Add antipsychotic medications as adjunct treatment when 
indicated. Oral thiamine, iv/im when evidence of Wernicke’s encephalopathy 
present or in the presence of severe malnutrition. Inpatient management 
when indicated. 
Preventing relapse in alcohol 
dependent patients
Offer acamprosate, disulfiram, or naltrexone for preventing relapse in alcohol 
dependent patients, depending on patient preference. 
Psychosocial interventions 
for management of alcohol 
dependence
Routine provision of psychosocial support is needed for patients with alcohol 
addiction, with provision of more structured therapies when possible. Family 
support should also be provided by non-specialist health care workers. 
Role of mutual help groups such 
as Alcoholics Anonymous (AA)
Refer patients with alcohol addiction to self-help groups, monitor attendance. 
Encourage family members of patients with alcohol addiction to attend family 
groups 
Drug use disorders
Brief psychosocial interventions Individuals using cannabis and psychostimulants should be offered brief 
intervention, which should comprise a single session of 5–30 minutes in 
duration, incorporating individualized feedback and advice on reducing or 
stopping cannabis/psychostimulant consumption, and the offer of follow up. 
People with ongoing problems related to their cannabis or psychostimulant 
drug use who do not respond to brief interventions 
should be considered for referral for specialist assessment.
Management of drug withdrawal 1) Cannabis, cocaine, or amphetamines: is best undertaken in a supportive 
environment. No specific medication is recommended for the treatment of 
their withdrawal. Relief of symptoms (e.g., agitation, sleep disturbance) may 
be achieved with symptomatic medication for the period of the withdrawal 
syndrome. If depression or psychosis can occur during withdrawal, monitor 
closely and seek advice from relevant specialists, if available. 
2) Benzodiazepines: convert to long acting benzodiazepines, gradually 
taper dose over 8–12 weeks. Additional psychosocial support should be 
considered. If severe withdrawal symptoms, seek specialist advice.
Treatment of psychostimulant 
dependence
Avoid using Dexamphetamine for the treatment of stimulant use disorders.
Psychosocial support for the 
management of cannabis 
dependence and abuse and 
psychostimulant use disorders
Brief motivational interviewing based psychological support; refer non 
responders for treatment in a specialist setting, when available.
Role of sterile injection 
equipment and outreach 
programmes for injecting 
drug users
Provision of sterile needs in primary care where injecting drug use is common 
and safe retrieval of used ones. This can be facilitated by community 
pharmacies or through outreach programmes. Testing for HIV and hepatitis is 
also necessary and referral to treatment is needed. 




The SRD service was established in Ze-
wditu Memorial Hospital, a general hos-
pital located at the heart of Addis Aba-
ba, named after Empress Zewditu, the 
cousin and predecessor on the throne 
of Emperor Haile Selassie. The Hospital 
is under the Addis Ababa Health Bureau. 
It provides health care to residents of 
Addis Ababa in different specialty and 
general medical services, including men-
tal health. The SRDs treatment center is 
found in the basement floor of the hos-
pital’s main building. It has a total of 4 in-
patient beds, nurses and doctor’s offices, 
and space for group therapy. The outpa-
tient service has been running since 2013, 
but the inpatient service   was opened on 
February fifteen 2016. Detoxification, in-
dividual psychotherapy, and group ther-
apy services are provided in the center, 
both on outpatient and inpatient basis. It 
also provides outpatient based individual 
counseling and weekly group therapy. 
This facility was established with limited 
financial support from WHO-Ethiopia 
country office, and the Federal Ministry 
of Health. 
Data Analysis
The current report is based on 
the cases admitted to the detoxification 
service in the first year of opening, March 
2016-April 2017, led by the author. Data 
was collected from the registry logbook 
and analyzed using SPSS Version 24. 
Descriptive statistics is presented to 
provide some baseline data. Narrative 
summary of the experience of setting 
up the SRD service including the 
challenges and opportunities is 
presented. 
RESULTS 
The majority of patients admitted were 
males (95.3%), aged ?30 years (69.8%), 
single (62.8%), had secondary education 
and above (86.1), and were living with 
their family (67.4%). Alcohol was the ma-
jor substance for admission (93%). Nearly 
half (48.8%) had used substance for ? 10 
years. (Please see table-3 for details).
Challenges faced when setting up the 
detoxification service
Experience of setting up the 
detoxification service
• The process of starting the detoxifica-
tion center started after the author 
returned from Canada in April 2012, 
completing a fellowship in addiction 
psychiatry. Although there was outpa-
tient based psychiatry service in the 
hospital, there was no service for SRDs. 
The author had to set up a designated 
outpatient service once a week in the 
afternoon in the same clinic where 
other general adult psychiatry patients 
were seen in the morning. There was 
no nurse or other auxiliary personnel 
trained in the evaluation and manage-
ment of SRDs. It was literally a ‘one 
man show’, plus psychiatry residents 
in training. The outpatient service was 
mainly based on individual therapy 
using motivational interviewing (MI) 
and CBT, and MI based group therapy. 
There were cases who had severe de-
pendence who needed admission. So, 
the process of setting up the inpatient 
detoxification service was started. It 
took three years to set up a 4 bed de-
toxification service at the basement of 
the main hospital- two years to secure 
the place and one year to get it ready 
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for the service. The author had to look 
for resources to renovate and parti-
tion the empty hall into a usable place. 
Some small funding was provided by 
the WHO country office and another 
small funding from the Federal Minis-
try of Health.
• As stated in the table, the number 
of cases admitted in the first year 
weren’t that many, but the impact 
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Table 3. Socio-demographic and Clinical Characteristics of Patients with SRDs Admitted 
to Zewditu Memorial Hospital Detoxification Unit, March 2016-April 2017
Characteristics Number % 
Sex Male 41 95.3 
Female 2 4.7 




50+ 2 4.7 
Marital Status Single 27 62.8
Married 11 25.6
Divorced/Widowed/Separated 5 11.6 
Education Primary 3 7.0 
Secondary 18 41.9
College 19 44.2 
Unspecified 3 7.0
Address Addis Ababa 38 88.4 
Other 8 18.6 
  Living arrangement 
With family 29 67.4
Alone 12 27.9
Unspecified 2 4.7
Type of Substance Used Alcohol 27 62.7 
Alcohol + Tobacco 5 11.6
Alcohol+ Tobacco+ Khat 6 13.9 
Opioids  (pethidine= 2, codeine=1) 3 7.0 
Alcohol + Cannabis 2 4.7
Duration of Substance Use < 10 years 9 20.9 
10-19 years 17 39.5 
20+ years 4 9.3 
Unspecified 13 30.2




 Length of stay in hospital 
Up to 14 days 12 27.9
15-28 days 20 46.5
>28 days 11 25.6
 Outcome of detoxification 
Successful 41 95.3
Not successful*** 2 4.7
***left the center before completing detoxification
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was powerful. The author engaged in 
continuous campaign using different 
media to advocate for attention to be 
given to the problem. Patient flow has 
been increasing since then. 
• Low priority given by the government: 
no alcohol and drug policy, and low at-
tention given to the problem. There was 
mention of alcohol as one of priority 
conditions in the recently expired five-
year national mental health strategy, 
but it was never implemented. There is 
also a ‘National Drug Master Plan’ writ-
ten every five years with the support of 
UNODC but poorly implemented. Treat-
ment of alcohol and drug use disorders 
is not covered in the ongoing national 
health insurance scheme. 
• Lack of awareness: In general, addic-
tion to alcohol and drugs is considered 
a moral failure and personal weakness 
and not as a health problem. Conse-
quently, there is low treatment seeking 
behavior both by patients themselves 
as well as their caregivers.
• Lack of resources: there is no training 
program in substance abuse counseling 
and treatment in the country except 
courses given to psychiatry nurses and 
residents which tend to be brief and 
inadequate to run a proper addiction 
treatment service. Currently, there is 
only one addiction psychiatrist trained 
abroad and two general psychiatrists 
who have been providing the service 
after receiving short courses. Besides 
the hospitals with a total capacity of 
about 20 beds, based in the capital city, 
there is one rehabilitation center dedi-
cated for addiction service, a 25 bed fa-
cility in the Northern Ethiopia regional 
state of Tigray which has a population 
of about 5 million. There are no drugs 
for detoxification of opioids such as 
methadone, buprenorphine, clonidine, 
naloxone or naltrexone, even thiamine. 
There are no medications for nicotine 
addiction such as nicotine replace-
ment therapies (NRTs) or Bupropion. 
No relapse prevention medications for 
alcohol such as disulfiram, naltrexone 
or acamprosate. In our detoxification 
service, we have been using tramadol 
protocol for detoxification from opioids 
which had comparable efficacy with 
buprenorphine, methadone or cloni-
dine for managing opioid withdrawal 
(Threlkeld, Parran, Adelman, Grey, 
2006; Sobey, Parran, Grey, Adelman, 
Yu, 2008; Zarghami, Masoum, Shiran, 
2012). For detoxification for alcohol, 
we have used diazepam protocol using 
standing dose and PRN administration 
according to the CIWA Ar score, and B 
vitamins preparations since thiamine 
was not available in the country. Unfor-
tunately, this low attention continues 
as evidenced by the complete exclu-
sion of medications used to manage 
addictions from the national drugs and 
supplies procurement list by the Phar-
maceuticals Fund and Supply Agency of 
Ethiopia (PFSA, 2018). 
•  Lack of self-help groups: in Ethiopia 
there are no self-help groups to refer 
patients for continued peer support. 
Repeated attempts to establish Alco-
holic Anonymous (AA) didn’t material-
ize. Only small groups run by expatriate 
recovering alcoholics exist in the coun-
try. 
• Lack of evidence base for effectiveness 
of interventions in Ethiopia: no stud-
ies have been conducted in Ethiopia 
on effectiveness of evidence-based in-
terventions for LMICs. The problem is 
more pronounced in some substances 
which are endemic to the country like 
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khat which lack empirically tested in-
terventions even in other parts of the 
world, although the diagnostic crite-
ria Stimulant Use Disorders, from the 
DSM, 5th edition, has been validated for 
diagnosing Khat Use Disorder (Duresso 
et al., 2016).
Opportunities 
• Although there were several challenges 
affecting SRD service in Ethiopia, there 
are also opportunities to be harnessed 
innovatively, namely, the inclusion of 
mental health in primary care, the at-
tention being given by the government 
on NCDs, and the recent media atten-
tion the issue has gained which cre-
ated an opportunity for advocacy. Al-
though limited, there are some NGOs 
working on SRDs, and these need to be 
strengthened. 
DISCUSSION 
The findings from this report are con-
sistent with the rest of the world, alco-
hol being the number one substance 
responsible for admission to detoxifica-
tion center. As it was reported by Willis 
(Willis, 2006), traditional alcoholic bever-
ages have been used in Africa for a long 
time, but recent massive investment from 
multinational breweries has changed the 
drinking culture, with a shift into manu-
factured alcoholic drinks such as beer and 
liquors; Ethiopia has been witnessing this 
transition (Teferra, et al., 2017). 
The other substance most commonly 
misused in Ethiopia is khat, an amphet-
amine-like shrub, chewed for its stimu-
lant effect (Teferra, et al. 2011). This sub-
stance is often used in combination with 
tobacco and alcohol. People drink alcohol 
to counter the stimulating effect of khat, 
which is locally known as ‘chebsi’, mean-
ing ‘breaking’ the effect of khat. Although 
not that alarming, prescription opioids 
such as pethidine are also misused in 
Ethiopia. The presence of the problem in 
itself warrants care when providing pre-
scription for these drugs to manage pain. 
Recent trends show the need for strict 
control of these drugs, and introduction 
of measures on pharmacies which sell 
these drugs without special prescription. 
The majority of patients admitted to 
the center were males. This is typical find-
ing in SUDs; males tend to have prepon-
derance for using addictive substances 
and getting admitted to detoxification 
facilities more than females. A similar 
study from Nigeria reported that 96.5% 
of patients admitted to the drug de-ad-
diction center were males (Unaogu, et 
al., 2017). Another report from Uganda 
showed a male to female ratio of 10 to 1 
for utilization of services for alcohol use 
disorders (Kalema et al., 2017). Substance 
use among women is taboo and highly 
stigmatized in African countries (Myers, 
2011, Kalema et al., 2017). 
As it is typical with alcohol use disorders, 
most patients had long history of drinking 
before they presented with severe signs 
of physical dependence which warranted 
inpatient detoxification (Hingson, Heeran 
& Winter, 2006). Routine administration 
of Clinical Institute Withdrawal Assess-
ment of Alcohol Scale, Revised (CIWA-Ar) 
was very useful and feasible in determin-
ing severe cases which needed admission. 
It was also useful for following progress 
and administering diazepam on as need-
ed basis when withdrawal symptoms 
were not controlled by the standing dose 
of benzodiazepines (Sullivan et al, 1989; 
Reoux &Miller, 2000). 
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Although detoxification was relatively 
easy to set up and very successful, the 
main challenge was after care as there 
were no rehabilitation facilities or self-
help groups to refer patients. In this set-
ting, patients were retained in the service 
for as long as possible, emphasis was 
given to attendance to group therapy at 
least once a week, and a one-on-one ses-
sion with a clinician for any psychologi-
cal symptoms that needed attention. Pa-
tients were provided the group therapy, 
mainly using motivational interviewing 
based five-session, groups developed by 
Ann Fields (Fields, 2005). Patients were 
encouraged to come to the group ses-
sions even after completing the five ses-
sions in order to retain them in the care 
to prevent relapse, since retention in care 
is necessary to prevent relapse (Murthy 
et al., 2009). Many challenges with SRD 
services were reported in other African 
countries such as Uganda. Challenges re-
ported from Uganda included lack of re-
sources, services, the treatment philoso-
phy of available services, and the lack of 
evidence on cultural appropriateness of 
treatment services for the African setting 
(Kalema et al., 2017).
Limitations of this study include lack 
of detailed review of policy documents 
and exploration of perspectives of policy 
makers, clinicians, service users on SRD 
services in Ethiopia. Restriction of the re-
port to inpatients and small sample size is 
another limitation. 
CONCLUSION 
This report has demonstrated that al-
cohol remains the most common sub-
stance misused in the community fol-
lowed by khat and tobacco, and a similar 
pattern was seen in the inpatient setting; 
hard drugs such as methamphetamine, 
cocaine and heroin were rare. It was pos-
sible to set up treatment services for al-
cohol and drugs, but due to limitations 
in the availability of resources, it was not 
possible to fully implement the evidence-
based treatment recommendations for 
LMICs fully. Innovative and pragmatic ap-
proaches are necessary. Evaluating the 
effectiveness of these interventions and 
their appropriateness in the cultural con-
text through research is recommended. 
Linking SRD services to government pri-
orities such as NCDs will probably help 
to draw their attention. Lessons learnt in 
this process have the potential to inform 
other similar services in LMIC countries. 
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